PRQR logo

ProQR Therapeutics NV (PRQR) Selling, General & Administrative Expenses

Annual SGA

$17.58 M
-$2.09 M-10.64%

December 31, 2023


Summary


Performance

PRQR SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPRQRexpensesmetrics:

Quarterly SGA

$3.61 M
+$366.50 K+11.30%

September 1, 2024


Summary


Performance

PRQR Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPRQRexpensesmetrics:

TTM SGA

-$1.79 B
-$48.01 M-2.75%

September 1, 2024


Summary


Performance

PRQR TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherPRQRexpensesmetrics:

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

PRQR Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-10.6%+0.0%-10000.0%
3 y3 years+12.5%-33.1%-7971.8%
5 y5 years+18.7%-33.1%-7971.8%

PRQR Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-14.5%at low-40.6%+18.8%-153.1%at low
5 y5-year-14.5%+21.8%-40.6%+18.8%-169.3%at low
alltimeall time-14.5%+1583.8%-40.6%+1289.8%<-9999.0%at low

ProQR Therapeutics NV Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sep 2024
-
$3.61 M(+11.3%)
$15.72 M(+0.0%)
Jun 2024
-
$3.24 M(-13.5%)
$15.72 M(-7.5%)
Mar 2024
-
$3.75 M(-26.7%)
$16.99 M(-3.3%)
Dec 2023
$17.58 M(-10.6%)
$5.12 M(+41.7%)
$17.57 M(+13.4%)
Sep 2023
-
$3.61 M(-20.1%)
$15.49 M(-10.4%)
Jun 2023
-
$4.52 M(+4.5%)
$17.28 M(-6.7%)
Mar 2023
-
$4.32 M(+42.3%)
$18.53 M(-6.0%)
Dec 2022
$19.67 M(-4.3%)
$3.04 M(-43.7%)
$19.71 M(-13.4%)
Sep 2022
-
$5.40 M(-6.4%)
$22.75 M(-0.1%)
Jun 2022
-
$5.76 M(+4.7%)
$22.77 M(+3.6%)
Mar 2022
-
$5.51 M(-9.4%)
$21.97 M(+7.2%)
Dec 2021
$20.55 M(+31.5%)
$6.08 M(+12.3%)
$20.48 M(+10.2%)
Sep 2021
-
$5.41 M(+9.0%)
$18.59 M(+12.9%)
Jun 2021
-
$4.97 M(+23.5%)
$16.46 M(+7.7%)
Mar 2021
-
$4.02 M(-3.9%)
$15.29 M(-1.9%)
Dec 2020
$15.63 M(+8.3%)
$4.19 M(+27.5%)
$15.59 M(-1.0%)
Sep 2020
-
$3.28 M(-13.4%)
$15.74 M(+0.4%)
Jun 2020
-
$3.80 M(-12.2%)
$15.68 M(+3.7%)
Mar 2020
-
$4.32 M(-0.3%)
$15.12 M(+4.8%)
Dec 2019
$14.43 M
$4.34 M(+34.4%)
$14.42 M(-6.2%)
Sep 2019
-
$3.23 M(-0.1%)
$15.38 M(+1.5%)
Jun 2019
-
$3.23 M(-10.9%)
$15.15 M(+0.5%)
DateAnnualQuarterlyTTM
Mar 2019
-
$3.62 M(-31.5%)
$15.08 M(+2.3%)
Dec 2018
$14.81 M(+20.6%)
$5.29 M(+76.5%)
$14.74 M(+14.7%)
Sep 2018
-
$3.00 M(-5.2%)
$12.85 M(-1.8%)
Jun 2018
-
$3.16 M(-3.6%)
$13.09 M(-0.1%)
Mar 2018
-
$3.28 M(-3.6%)
$13.11 M(+6.7%)
Dec 2017
$12.28 M(+17.0%)
$3.40 M(+5.2%)
$12.28 M(+8.5%)
Sep 2017
-
$3.24 M(+1.7%)
$11.31 M(+9.7%)
Jun 2017
-
$3.18 M(+29.6%)
$10.31 M(+2.3%)
Mar 2017
-
$2.45 M(+0.7%)
$10.08 M(-4.0%)
Dec 2016
$10.49 M(+38.3%)
$2.44 M(+9.2%)
$10.50 M(+2.4%)
Sep 2016
-
$2.23 M(-24.4%)
$10.25 M(+6.4%)
Jun 2016
-
$2.95 M(+2.9%)
$9.63 M(+11.5%)
Mar 2016
-
$2.87 M(+31.2%)
$8.64 M(+14.0%)
Dec 2015
$7.59 M(-12.3%)
$2.19 M(+35.0%)
$7.58 M(-3.9%)
Sep 2015
-
$1.62 M(-17.5%)
$7.89 M(-16.3%)
Jun 2015
-
$1.96 M(+8.6%)
$9.42 M(-1.5%)
Mar 2015
-
$1.81 M(-27.5%)
$9.56 M(+11.6%)
Dec 2014
$8.65 M(+728.9%)
$2.49 M(-20.9%)
$8.57 M(+30.9%)
Sep 2014
-
$3.15 M(+49.8%)
$6.55 M(+79.3%)
Jun 2014
-
$2.11 M(+158.3%)
$3.65 M(+136.2%)
Mar 2014
-
$815.20 K(+73.1%)
$1.55 M(+111.5%)
Dec 2013
$1.04 M
$471.00 K(+81.3%)
$730.80 K(+181.3%)
Sep 2013
-
$259.80 K
$259.80 K

FAQ

  • What is ProQR Therapeutics NV annual SGA?
  • What is the all time high annual SGA for ProQR Therapeutics NV?
  • What is ProQR Therapeutics NV annual SGA year-on-year change?
  • What is ProQR Therapeutics NV quarterly SGA?
  • What is the all time high quarterly SGA for ProQR Therapeutics NV?
  • What is ProQR Therapeutics NV quarterly SGA year-on-year change?
  • What is ProQR Therapeutics NV TTM SGA?
  • What is the all time high TTM SGA for ProQR Therapeutics NV?
  • What is ProQR Therapeutics NV TTM SGA year-on-year change?

What is ProQR Therapeutics NV annual SGA?

The current annual SGA of PRQR is $17.58 M

What is the all time high annual SGA for ProQR Therapeutics NV?

ProQR Therapeutics NV all-time high annual SGA is $20.55 M

What is ProQR Therapeutics NV annual SGA year-on-year change?

Over the past year, PRQR annual SGA has changed by -$2.09 M (-10.64%)

What is ProQR Therapeutics NV quarterly SGA?

The current quarterly SGA of PRQR is $3.61 M

What is the all time high quarterly SGA for ProQR Therapeutics NV?

ProQR Therapeutics NV all-time high quarterly SGA is $6.08 M

What is ProQR Therapeutics NV quarterly SGA year-on-year change?

Over the past year, PRQR quarterly SGA has changed by +$1400.00 (+0.04%)

What is ProQR Therapeutics NV TTM SGA?

The current TTM SGA of PRQR is -$1.79 B

What is the all time high TTM SGA for ProQR Therapeutics NV?

ProQR Therapeutics NV all-time high TTM SGA is -$5.07 M

What is ProQR Therapeutics NV TTM SGA year-on-year change?

Over the past year, PRQR TTM SGA has changed by -$1.81 B (-11659.79%)